Overview

A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain

Status:
Completed
Trial end date:
2019-08-27
Target enrollment:
Participant gender:
Summary
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain.
Phase:
Phase 2
Details
Lead Sponsor:
Charleston Laboratories, Inc
Treatments:
Diphenhydramine
Promethazine
Sumatriptan